Oruka Therapeutics Inc (ORKA)

SG&A Expenses

$6.81M

Quarterly · Period ending: · USD

ORKA logo

ORKA SG&A Expenses

Latest reported$6.81M
ORKA Quarterly SG&A Expenses ($1.13M → $6.81M)
High-resolution chart · PNG

ORKA sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Oruka Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
6,807,000
7,246,000
6,763,000
5,117,000
4,342,000
5,161,000
6,002,544
3,758,000
2,820,000
1,670,000
1,520,000
1,585,000
1,690,000
1,377,000
1,288,000
1,200,000
1,405,000
1,070,000
1,711,000
1,251,000
1,241,000
1,209,000
1,906,000
913,000
912,000
950,000
870,000
878,000
1,046,000
1,098,000
897,000
916,000
997,000
1,046,999
1,457,000
980,000
1,044,000
1,128,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.